Peripheral T-cell lymphoma with t(6;14)(p25;q11.2) translocation presenting with massive splenomegaly |
| |
Authors: | Joan Somja Bettina Bisig Christophe Bonnet Christian Herens Reiner Siebert Laurence de Leval |
| |
Affiliation: | 1. Department of Pathology, B35, University of Liege, CHU Sart Tilman, Liege, Belgium 2. Institute of Pathology, CHUV, University Hospital Lausanne, 25 rue du Bugnon, 1011, Lausanne, Switzerland 3. Department of Hematology, University of Liege, CHU Sart Tilman, Liege, Belgium 4. Department of Human Genetics, University of Liege, CHU Sart Tilman, Liege, Belgium 5. Institute of Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
|
| |
Abstract: | Recurrent chromosomal translocations associated to peripheral T-cell lymphomas (PTCL) are rare. Here, we report a case of PTCL, not otherwise specified (NOS) with the karyotype 46,Y,add(X)(p22),t(6;14)(p25;q11) and FISH-proved breakpoints in the IRF4 and TCRAD loci, leading to juxtaposition of both genes. A 64-year-old male patient presented with mild cytopenias and massive splenomegaly. Splenectomy showed diffuse red pulp involvement by a pleomorphic medium- to large-cell T-cell lymphoma with a CD2+ CD3+ CD5? CD7? CD4+ CD8+/? CD30? TCRbeta-F1+ immunophenotype, an activated cytotoxic profile, and strong MUM1 expression. The clinical course was marked by disease progression in the bone marrow under treatment and death at 4 months. In contrast with two t(6;14)(p25;q11.2)-positive lymphomas previously reported to be cytotoxic PTCL, NOS with bone marrow and skin involvement, this case was manifested by massive splenomegaly, expanding the clinical spectrum of PTCLs harboring t(6;14)(p25;q11.2) and supporting consideration of this translocation as a marker of biological aggressiveness. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|